HealthEquity (NASDAQ:HQY) Releases FY 2026 Earnings Guidance

HealthEquity (NASDAQ:HQY) updated its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 3.570-3.740 for the period, compared to the consensus EPS estimate of 3.760. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on HQY. JMP Securities upped their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Raymond James lifted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday, February 25th. Royal Bank of Canada upped their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Wells Fargo & Company upped their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Finally, Barrington Research reissued an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a research note on Friday. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $112.92.

HealthEquity Stock Up 0.9 %

HealthEquity stock traded up $0.95 during mid-day trading on Tuesday, reaching $101.67. The company’s stock had a trading volume of 1,984,479 shares, compared to its average volume of 661,292. The company has a market capitalization of $8.81 billion, a price-to-earnings ratio of 93.28, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59. The business’s 50 day simple moving average is $105.76 and its 200 day simple moving average is $95.51. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, March 18th. The company reported $0.55 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.16). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. As a group, research analysts anticipate that HealthEquity will post 2.32 earnings per share for the current year.

Insider Buying and Selling at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.